Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Restore Robotics received FDA 510(k) clearance March 2025 for remanufacturing Da Vinci Xi Monopolar Curved Scissors, subsequently achieving first in human use with remanufactured instruments that have shown equivalent safety and efficacy to factory-new ones in clinical use at major hospital systems nationwide. Further FDA clearances for additional Da Vinci Xi instruments are being pursued.[3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Restore Robotics.